On Monday (April 15), Horizons ETFs Management (Canada) confirmed the launch date and holdings for its US-centric marijuana exchange-traded fund (ETF).

The Horizons US Marijuana Index ETF will start trading on Thursday (April 18) under the ticker symbol HMUS on the NEO Exchange.


This new fund is designed to offer investors exposure to the budding US cannabis and hemp markets.

More specifically, shareholders of the fund will gain access to a public index overseeing multi-state operators (MSOs), one of the latest investing trends in the marijuana market.

Steve Hawkins, president and CEO of Horizons ETFs, said his firm expects that the interest of marijuana investors for the US market will continue to rise.

“As the US continues to further liberalize its marijuana regulations, we anticipate that more investors will be looking to invest in companies with significant business operations in the US market, and HMUS will provide a diversified and liquid way to gain that exposure in one ETF,” he said in the press release.

According to Horizons ETFs, in order to be added to the index, a company will need a market capitalization greater than C$75 million.

The new fund from Horizons ETFs will carry apply a 0.85 percent management fee for investors.

The NEO Exchange, an emerging exchange in Canada, does not limit listings from operating in the US marijuana space, unlike exchanges operated by TMX Group (TSX:X).

This represents the second NEO Exchange index for Horizons ETFs. In February 2018, the firm launched its first ETF, the Horizons Emerging Marijuana Growers Index ETF (NEO:HMJR), which offers exposure to smaller cap marijuana growers.

While HMUS will trade on a Canadian exchange, a version trading under the ticker symbol HMUS.U will be made available at a US dollar rate.

Some of the initial holdings confirmed for HMUS have already been added to existing ETFs from the firm.

As part of its most recent quarterly rebalance for the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ), hemp-derived cannabidiol producer Charlotte’s Web Holdings (CSE:CWEB,OTCQX:CWBHF) was added to the index.

Charlotte’s Web, which produces a variety of novelty legal CBD products, currently holds a 10.96 percent weight in HMUS, according to Horizons ETFs.

Additionally, some of the top holdings for HMJR are additions to the new HMUS fund.

At the time, Hawkins hinted that Horizons ETFs wanted to pursue more hemp-derived CBD opportunities in the public market.

This sector of the entire marijuana space has seen a boost in investment thanks to the legalization of hemp and its derivatives in the US in December 2018.

While this will be the first fund from Horizons ETFs to exclusively focus on the US market, fellow ETF operator Evolve Funds Group is also set to launch its own US-specific ETF.

The two funds will both list on the NEO Exchange, but the Evolve fund, dubbed the Evolve US Marijuana ETF (USMJ), will be actively managed by Elliot Johnson, chief investment officer with Evolve ETFs.

Here is a list of all the holdings in the new Horizons ETFs fund:

  • Curaleaf Holdings (CSE:CURA,OTCQX:CURLF)
  • Cresco Labs (CSE:CL,OTCQX:CRLBF)
  • Charlotte’s Web
  • MedMen Enterprises (CSE:MMEN,OTCQX:MMNFF)
  • Green Thumb Industries (CSE:GTII,OTCQX:GTBIF)
  • Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF)
  • iAnthus Capital Holdings (CSE:IAN,OTCQX:ITHUF)
  • Green Growth Brands (CSE:GGB,OTCQB:GGBXF)
  • TerrAscend (CSE:TER,OTCQX:TRSSF)
  • CannaRoyalty operating as Origin House (CSE:OH,OTCQX:ORHOF)
  • Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF)
  • Flower One Holdings (CSE:FONE,OTCQB:FLOOF)
  • Slang Worldwide (CSE:SLNG)
  • Cannabis One Holdings (CSE:CBIS)
  • Liberty Health Sciences (CSE:LHS,OTCQX:LHSIF)
  • Valens GroWorks (CSE:VGW,OTCQB:VGWCF)
  • Cannabis Strategies Acquisition (NEO:CSA)
  • Planet 13 Holdings (CSE:PLTH,OTCQB:PLNHF)
  • Trulieve Cannabis (CSE:TRUL,OTC Pink:TCNNF)
  • Sunniva (CSE:SNN,OTCQB:SNNVF)

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings, Green Growth Brands, Flower One Holdings and Valens GroWorks are clients of the Investing News Network. This article is not paid-for content.

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less